Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Pediatrix Medical Group, Inc.

Stage 2 · Advancing · week 26

As of Oct 22, 2026, Pediatrix Medical Group is in Stage 2, the uptrend phase, now in week 26 (since Apr 22, 2026). It closed at $29.55, at its 52-week high and above its 200-day average, which is rising.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. More about the company

$29.55
+5.16% today
$2.4B · Mid cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is MD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 22w
S4 22w
S2 20w
S2 23w
S2 26w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 4w → S4 22w → S1 3w → S4 22w → S1 4w → S2 20w → S3 6w → S2 7w → S3 10w → S2 2w → S1 1w → S4 3w → S1 1w → S2 23w → S3 10w → S2 26w current
Total tracked: 165 weeks across 16 stage runs.

MD among Medical Care Facilities8th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
vs 52W High
0.0%
$16.97 lo$29.55 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 26
1w13w26w
Week 26, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
24.9%
200 DMA: $23.66 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.51x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+14.3%
3M
+12.5%
6M
+29.8%
YTD
+38.8%
1Y
+74.9%
Scan Membership
Breakout Watch
Latest: 2025-03-07
7 appearances in last 60 days. First seen: 2019-12-19.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 26 · Vol 1.51x
2026-10-21S2
Wk 26 · Vol 0.61x
2026-10-20S2
Wk 26 · Vol 0.97x
2026-10-19S2
Wk 25 · Vol 0.62x
2026-10-16S2
Wk 25 · Vol 0.72x
2026-10-15S2
Wk 25 · Vol 0.62x
2026-10-14S2
Wk 25 · Vol 1.49x
2026-10-13S2
Wk 25 · Vol 0.59x
2026-10-12S2
Wk 24 · Vol 0.63x
2026-10-09S2
Wk 24 · Vol 0.66x
2026-10-08S2
Wk 24 · Vol 0.93x
2026-10-07S2
Wk 24 · Vol 0.84x
Moving averages & range
50 DMA
$26.60
200 DMA
$23.66
52W High
$29.55
52W Low
$16.97
5D Low
$27.30
Resistance levels (recent highs)
20d High
$29.55
60d High
$29.55
120d High
$29.55
250d High
$29.55
Next resistance
Above all
P/E (TTM)
14.1
Forward 12.1
Earnings Growth (YoY)
+6.5%
Revenue +4.0%
ROE
+20.4%
Profit margin +9.0%
Dividend Yield
0.00%
P/B 2.7

Pediatrix Medical Group: quick answers

What stage is Pediatrix Medical Group in?

As of Oct 22, 2026, Pediatrix Medical Group (MD) is in Stage 2, the uptrend phase. It entered Stage 2 on Apr 22, 2026 and is in week 26. What the four stages mean

Is Pediatrix Medical Group in an uptrend?

Yes. Pediatrix Medical Group is in a Stage 2 uptrend. It trades 24.9% above its 200-day average, which is rising.

How far is Pediatrix Medical Group from its 52-week high?

Pediatrix Medical Group closed at $29.55 on Oct 22, 2026, at its 52-week high. Its 52-week low is $16.97.

How has Pediatrix Medical Group performed over the past year?

As of Oct 22, 2026, Pediatrix Medical Group is up 74.9% over the past year and up 38.8% so far in 2026.

Which sector and industry is Pediatrix Medical Group in?

Pediatrix Medical Group is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.